Koers Scythian Biosciences Corp Canadian Securities Exchange
Aandelen
CA7840531007
Beleggingsbeheer & Fondsbeheerders
Omzet 2022 | -235,54 -321,4 -216,88 | Omzet 2023 | -31,51 -43 -29,02 | Marktkapitalisatie | 6,26 mln. 8,54 mln. 5,76 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | -297 mln. -405 mln. -273 mln. | Nettowinst (verlies) 2023 | -34 mln. -46,39 mln. -31,31 mln. | EV/omzet 2022 | -188.347 x |
Nettoschuld 2022 | 24,76 mln. 33,79 mln. 22,8 mln. | Nettoliquiditeiten 2023 | 70,4 mln. 96,06 mln. 64,82 mln. | EV/omzet 2023 | 2.035.264 x |
K/w-verhouding 2022 |
-0,07
x | K/w-verhouding 2023 |
-0,18
x | Werknemers | - |
Dividendrendement 2022 * |
-
| Dividendrendement 2023 |
-
| Vrij verhandelbaar | 91,99% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Paul Kania
CEO | Chief Executive Officer | - | 19-05-20 |
Deena Siblock
BRD | Director/Board Member | - | 27-02-23 |
Corporate Officer/Principal | - | 17-04-18 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Mehdi Azodi
BRD | Director/Board Member | - | 27-02-23 |
Deena Siblock
BRD | Director/Board Member | - | 27-02-23 |
Jason Batista
BRD | Director/Board Member | - | 07-06-23 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
-0,54% | 34,94 mld. | |
0,00% | 20,89 mld. | |
+4,34% | 5,54 mld. | |
+8,33% | 3,37 mld. | |
+21,76% | 2,92 mld. | |
+8,08% | 2,79 mld. | |
-18,12% | 2,39 mld. | |
+9,87% | 1,26 mld. | |
+3,02% | 1,22 mld. |